BioSpace News Archive

Deals

GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities

GC corp. announced that it has signed a definitive agreement to acquire 100% of the shares of BioCentriq, Inc., a pioneering US-based contract development and manufacturing organization that designs and develops scalable cell and gene technologies.

April 19, 2022
·
2 min read
Microviable Therapeutics Announces 1.5 Million Euros Investment to Advance the Company´s Microbiota-Derived Biotherapeutic Products

Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL.

April 19, 2022
·
2 min read
Policy

Gastroenterology: NTC submits marketing authorisation application for KLEERKOL® in EU

NTC Srl, R&D driven pharmaceutical company with headquarters in Italy announces the submission of the marketing authorisation application through the European Decentralised Procedure for its development product NTC015 for bowel preparation for colonoscopy.

April 19, 2022
·
2 min read
Business

Turnstone Biologics Announces Executive Leadership Appointments

Turnstone Biologics Corp. announced the appointments of Venkat Ramanan, Ph.D., as Chief Financial Officer, and P. Joseph Campisi Jr., J.D., M.B.A., as General Counsel.

April 19, 2022
·
4 min read
Pharm Country

Johnson & Johnson Announces Dividend Increase of 6.6%

Johnson & Johnson announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share.

April 19, 2022
·
1 min read
Business

Johnson & Johnson Reports Q1 2022 Results

Johnson & Johnson announced results for first-quarter 2022. “Our first quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds.

April 19, 2022
·
24 min read
Business

Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022

Sage Therapeutics, Inc. announced that it will host a live webcast on Tuesday, May 3, 2022 at 8:00 a.m. ET to announce first quarter 2022 financial results and discuss recent business updates.

April 19, 2022
·
1 min read
Business

Omniose Announces Expanded Leadership Team to Develop Bioconjugate Vaccines Against Serious Bacterial Threats

Omniose announced the expansion of the leadership team to include Timothy Cooke, Ph.D., MBA as Chief Executive Officer and Roman Fleck.

April 19, 2022
·
2 min read
Pharm Country

Humanigen Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS

Humanigen, Inc. announced a peer-reviewed publication in ClinicoEconomics and Outcomes Research outlining the potential clinical and health economic benefits of lenzilumab, if authorized or approved for use in the United Kingdom.

April 19, 2022
·
7 min read
Policy

Algenex Announces GMP Certification

Algenex announces that it has received the final audit report from the Spanish Agency for Medicines and Health Products in which they confirm that Algenex complies with the principles of the Good Manufacturing Practices for active substances of the European Union.

April 19, 2022
·
2 min read